Matched on what Next Vial offers: medications, brand-name access, the video visit, an oral option, price and where it serves. Each one links to our full review.
No recurring price we could quote
TeleHealth Med’s public responses do not establish current semaglutide and tirzepatide monthly totals. Its alternate site shows a $1,997 GLP-1 figure without a clear applicable supply period.
Why it's here: the same medications, compounded medication and no video visit.
- Neither TeleHealth Med nor Next Vial requires a live video visit to get started.
No recurring price we could quote
Earlier Neo Soma pages described a six-week semaglutide introductory offer followed by four-week billing, and a separate six-week tirzepatide purchase.
Why it's here: the same medications, compounded medication and no video visit.
- Neither Neo Soma Healthcare nor Next Vial requires a live video visit to get started.
No recurring price we could quote
Actin’s current public product page did not expose a readable price or plan menu. Its previously listed medication rates remain unconfirmed.
Why it's here: the same medications, compounded medication and no video visit.
- Neither Actin nor Next Vial requires a live video visit to get started.
No recurring price we could quote
VitaStir previously listed one-time 30-day medication kits. Current kit prices, shipping charges and reorder terms could not be confirmed.
Why it's here: the same medications, compounded medication and no video visit.
- Neither VitaStir nor Next Vial requires a live video visit to get started.
No recurring price we could quote
HumeCare combines physician-guided GLP-1 care with body-composition tracking and a free app. Current medication prices are not published on the homepage.
Why it's here: the same medications, compounded medication and no video visit.
- Neither HumeCare+ nor Next Vial requires a live video visit to get started.
- HumeCare+ lists an oral option (a pill or under-the-tongue form); Next Vial doesn't.
- HumeCare+ lists a narrower service area; Next Vial doesn't publish a full state list.
No recurring price we could quote
Peter MD advertises tirzepatide at $149 to start, then $249 per month billed quarterly for a 60 mg option.
Why it's here: compounded medication and no video visit.
- Peter MD also offers tirzepatide, which we didn't find at Next Vial.
- Neither Peter MD nor Next Vial requires a live video visit to get started.
- Peter MD lists a narrower service area; Next Vial doesn't publish a full state list.